Financings in Brief: Caring Products International
This article was originally published in The Gray Sheet
Executive Summary
Caring Products International: Nets approximately $7.2 mil. from a secondary offering of about 1.8 mil. units at $5 each on Dec. 9. The units -- which trade on the NASDAQ SmallCap Market under the symbol "BDRYU" -- consist of one share of CPI common stock and one warrant to purchase an additional share at $7.50. After 30 days, the common stock and warrants will trade separately under the symbols "BDRY" and "BDRYW," respectively. Proceeds will be used to support marketing efforts for the Seattle-based firm's Rejoice absorbent bladder control product, which debuted in late 1994. Paulson Investment Company and Cohig & Associates served as underwriters...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.